Management of complicated pediatric rhinosinusitis in the COVID-19 era

Conor H Blanco1, John B Stein1, Gregory L Barinsky1

  • 1Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.

Insights

This study addresses complicated rhinosinusitis in pediatric COVID-19 patients. It outlines a multidisciplinary treatment strategy and presents case examples for managing these challenging cases.

Area of Science:

  • Otolaryngology
  • Pediatric Infectious Diseases
  • Critical Care Medicine

Background:

  • The COVID-19 pandemic presents unique challenges in pediatric care.
  • Complicated rhinosinusitis in children requires specialized management.
  • Limited literature exists on managing pediatric COVID-19 patients with complicated rhinosinusitis.

Observation:

  • This report details a multidisciplinary approach for pediatric patients with complicated rhinosinusitis and COVID-19.
  • Two distinct case examples illustrate varied treatment strategies.
  • The study focuses on preoperative, intraoperative, and postoperative management.

Findings:

  • A comprehensive, multidisciplinary strategy is crucial for managing pediatric complicated rhinosinusitis in COVID-19 patients.
  • Different treatment approaches can be effective depending on individual case characteristics.
  • The report offers practical insights and pearls for clinicians.

Implications:

  • This work provides a valuable framework for treating pediatric patients with complicated rhinosinusitis during the COVID-19 pandemic.
  • It highlights the need for tailored, multidisciplinary care in this specific patient population.
  • The findings can inform clinical practice and future research in pediatric otolaryngology and infectious diseases.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
284
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
612
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
2.0K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
493
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
394
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
321